Enrique Alvarez

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 6

Top Topics

Multiple Sclerosis

Clinical Practice

Top Venues

Annals of clinical and translational neurology

Journal of medical Internet research

Neurorehabilitation and neural repair

This page only lists publications with an associated author ORCID identifier.

Publications

Roger M Enoka, Awad M Almuklass, Mohammed Alenazy, Enrique Alvarez, Jacques Duchateau
Distinguishing between Fatigue and Fatigability in Multiple Sclerosis. Neurorehabilitation and neural repair 35 (11) (2021)
Tjalf Ziemssen, Gavin Giovannoni, Enrique Alvarez, Virender Bhan, Carrie M Hersh, Olaf Hoffmann, Celia Oreja-Guevara, Rene R Robles-Cedeño, Maria Trojano, Patrick Vermersch, Maria Pamela Dobay, Mudeer Khwaja, Bianca Stadler, Benedict Rauser, Thomas Hach, Daniela Piani-Meier, Jason Burton
Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey. Journal of medical Internet research 23 (10) (2021)
Brandi L Vollmer, Asya I Wallach, John R Corboy, Karolina Dubovskaya, Enrique Alvarez, Ilya Kister
Serious safety events in rituximab-treated multiple sclerosis and related disorders. Annals of clinical and translational neurology 7 (9) (2020)
Brandi L Vollmer, Kavita Nair, Stefan Sillau, John R Corboy, Timothy Vollmer, Enrique Alvarez
Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment. Annals of clinical and translational neurology 7 (9) (2020)
Justin M Honce, Kavita V Nair, Stefan H Sillau, Brooke Valdez, Augusto Miravalle, Enrique Alvarez, Teri Schreiner, John R Corboy, Timothy R Vollmer
Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis. Neurology 92 (7) (2019)
Natalia V Voge, Enrique Alvarez
Monoclonal Antibodies in Multiple Sclerosis: Present and Future. Biomedicines 7 (1) (2019)